ArticleBiologics : targets & therapy2021

An Australian Real-World Study of Treatment Persistence of Ustekinumab in Crohn's Disease.

Tzu Hsiang Chien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.